Back to Search Start Over

Discovery of 4-(phenoxymethyl)-1H-1,2,3-triazole derivatives as novel xanthine oxidase inhibitors.

Authors :
Zhang TJ
Zhang Y
Zhang ZH
Wang ZR
Zhang X
Hu SS
Lu PF
Guo S
Meng FH
Source :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2022 Mar 15; Vol. 60, pp. 128582. Date of Electronic Publication: 2022 Jan 22.
Publication Year :
2022

Abstract

A series of 4-(phenoxymethyl)-1H-1,2,3-triazole derivatives were designed, synthesized, and evaluated for their xanthine oxidase (XO) inhibitory activities. Among these compounds, 9m emerged as the most effective XO inhibitor with an IC <subscript>50</subscript> value of 0.70 μM, which was approximately 14-fold more potent than allopurinol. Additionally, compound 9m displayed favorable drug-like properties with ligand efficiency (LE) and lipophilic ligand efficiency (LLE) values of 0.33 and 3.41, respectively. We further explored the binding mode of 9m in complex with XO by molecular docking and molecular dynamics studies. In vivo hypouricemic studies also suggested that 9m could effectively lower the serum uric acid levels of rat. In summary, compound 9m could be a promising lead for further development of XO inhibitors.<br /> (Copyright © 2022 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1464-3405
Volume :
60
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
35077850
Full Text :
https://doi.org/10.1016/j.bmcl.2022.128582